Literature DB >> 8078269

[Preliminary results of observing 18 cases of retinoblastoma carried within the international research program RICS].

H Zygulska-Mach1, K Krukar-Baster, K Sajak-Hydzik.   

Abstract

In the years 1988-1989, the Ophthalmological Clinic in Cracow took part in the International Research Programme on Retinoblastoma as one of 28 clinical centres in 14 countries. The study included 18 children with retinoblastoma, in most cases in the advanced stadium of the disease. As a rule, the eyes filled with tumours were enucleated, and the less advanced cases were treated with combined methods applying radiation with 60Co plaques with xenon arc photocoagulation, cryopexy, and chemotherapy. In 18 treated children 23 eyes were enucleated (in 5 children both eyes, in 6 children with bilateral retinoblastoma 1 eye, and 7 eyes in all unilateral cases). Six eyes with less advanced lesions were treated with combined methods. One child died because of metastases to the brain. The obtained data reveal that retinoblastoma is diagnosed too late, which decreases the chance of cure and causes great danger for the life of the child.

Entities:  

Mesh:

Year:  1994        PMID: 8078269

Source DB:  PubMed          Journal:  Klin Oczna        ISSN: 0023-2157


  2 in total

1.  A multicentre report from the Mexican Retinoblastoma Group.

Authors:  C Leal-Leal; M Flores-Rojo; A Medina-Sansón; F Cerecedo-Díaz; S Sánchez-Félix; O González-Ramella; F Pérez-Pérez; R Gómez-Martínez; A Quero-Hernández; E Altamirano-Alvarez; F Alejo-González; J Figueroa-Carbajal; A Ellis-Irigoyen; I Tejocote-Romero; R Cervantes-Paz; F Pantoja-Guillén; L Vega-Vega; F Carrete-Ramírez
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

2.  Epidemiological Characteristics of Retinoblastoma in Children Attending Almouassat University Hospital, Damascus, Syria, 2012-2016

Authors:  Ahmad Al Hasan; Rashad Murad; Khaldoun Zaid; Jourjous Al Daoud; Khaled Zaid
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.